Highlights From Altria’s 4th-Quarter Earnings Call

MarketBusiness
Feb.08.2023
Company says smokers switching to cheaper options; gives update on innovation

Hannah Hammond of cspdailynews.com

 

High inflation rates in 2022 affected tobacco consumer’s behaviors, discretionary income and spending, Altria said in its fourth-quarter 2022 earnings report.

 

“As a result, our businesses and the industry experienced elevated volume declines, and we observed accelerated share growth in discount cigarettes,” the Richmond, Virginia-based tobacco company said. “Despite these factors, our leading tobacco brands remained resilient, and we continued to observe significant brand loyalty in the tobacco space overall.”

 

Net revenues decreased 2.3% to $6.1 billion in fourth quarter 2022, primarily driven by lower net revenues in the smokeable products segment, Altria said. For the full year 2022, net revenues were down 3.5% to $25.1 billion year-over-year. This was primarily driven by the sale of Altria’s former Ste. Michelle wine business in October 2021, the company said, and lower net revenues in the smokeable products segment.

 

Cigarette Sales Sink

 

Altria’s cigarette sales volume sunk by about 12% in the fourth quarter of 2022. The consumer remains under pressure, Altria’s CEO Billy Gifford said at the company’s Feb. 1 earnings call, which is causing them to smoke fewer cigarettes per day and switch to cheaper brands.

 

Marlboro’s, Altria’s flagship cigarette brand, retail share of the total cigarette category decreased 0.4 share points to 42.5% in the fourth quarter. This was primarily due to increased macroeconomic pressures on the adult tobacco consumer’s disposable income and increased competitive activity, Altria said.

 

However, Marlboro’s share of the premium segment grew to 58.2%, an increase of 0.5% share points.

 

“We are encouraged by Marlboro’s resilient performance as the brand celebrates 50 years of leadership in the cigarette category,” Sal Mancuso, Altria’s CFO, said on the call.

 

Nicotine Pouches Increase Share

 

The U.S. nicotine pouch category grew to 24.4% of the U.S. oral tobacco category in fourth quarter 2022, an increase from the year prior. Altria’s modern oral nicotine (MON) pouch On grew its share 2.5 points versus the prior year to 24%, Altria said. 

 

“This impressive performance was driven by continued increases in brand awareness and adoption by smokers and dippers,” Gifford said. “Additionally, we believe Helix effectively managed On promotional spend as the year progressed and reduced On promotional spend per can by approximately 15% during the second half of the year compared to the first half.”

 

 Altria established Helix Innovations LLC in 2019 to commercialize and distribute On.

 

Innovation Progresses

 

Gifford also highlighted the company’s progress in innovation.

 

“In oral tobacco product development, we are excited to announce we have finalized a new product design, which will provide tobacco consumers more smoke-free options within our portfolio,” he said. “We also began regulatory preparations for the product, and we are encouraged by the initial research results and the response we have received from dippers and nicotine pouch users.”

 

More information on the product will be released at Altria’s investor day in March, he said.

 

Altria has not finalized the design of its heated tobacco capsule product, but the team is making progress, Gifford said. It also announced a strategic partnership with Japan Tobacco in October to eventually bring heated tobacco sticks, made of Ploom-branded devices and Marlboro-branded consumables, to the United States.

 

Juul Devalued

 

E-vapor has been a major contributor to the growth of smoke-free products over the five-year period, Gifford said, although volumes declined by an estimated 1% year-over-year amid considerable regulatory uncertainty, such as the FDA marketing denial order and subsequent temporary stay on Juul products. This cause disruptions for both consumers and retailers, he said.

 

As of Dec. 31, 2022, the estimated fair value of Altria’s investment in Juul was $250 million. This is a significant drop from the initial value of Juul when Altria invested a 35% stake in the company in 2018.

 

In September, when Altria announced it was ending its noncompete agreement with Juul, San Francisco, it said it valued its investment in Juul at $450 million. Juul did not respond back to CSP’s request for comment on its devaluation.

*The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the original author and refrain from forwarding directly from here.

U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15
 NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift
NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift
According to The New York Times, Reynolds American donated $5 million to a Trump-backed super PAC shortly before the FDA introduced a new policy that could benefit major tobacco companies seeking to sell flavored vaping products.
News
May.21
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
 RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
Richard Danker, a senior public affairs official in Health Secretary Robert F. Kennedy Jr.’s team, resigned from his role at HHS over the FDA’s recent authorization of fruit-flavored vaping products. In a resignation letter addressed to President Donald Trump, Danker argued that the products could expose minors to nicotine addiction, lung damage, and increased cancer risks, while also conflicting with recent HHS guidance on youth risks associated with flavored nicotine products.
News
May.15
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
U.S. Customs and Border Protection (CBP) announced that more than 18 million illegal e-cigarettes valued at over $175 million were seized during “Operation Red Mist,” a joint enforcement initiative involving the U.S. Coast Guard and the FDA. The operation primarily targeted maritime vape shipments originating from China and focused on combating illicit importation, transportation, and distribution activities.
Regulations
May.14
Exclusive | TPE 2026 Cools as Caution Deepens in the U.S. Vape Market
Exclusive | TPE 2026 Cools as Caution Deepens in the U.S. Vape Market
The show had become an important check-in point for Chinese manufacturers and brand owners looking for signs of change in the U.S. market after months of softer demand. Instead, participants said the event highlighted a more restrained mood: traffic in the vape section was uneven, standout launches were limited, and conversations often failed to turn into orders.
Special Report
Apr.12